Matches in Nanopublications for { ?s ?p "[Immunohistochemical detection of expression of the epidermal growth factor receptor (EGFR) has been utilized to identify eligible patients with solid malignant tumors, including colorectal adenocarcinoma, for monoclonal antibody therapy (eg, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_assertion description "[Immunohistochemical detection of expression of the epidermal growth factor receptor (EGFR) has been utilized to identify eligible patients with solid malignant tumors, including colorectal adenocarcinoma, for monoclonal antibody therapy (eg, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731241.RAUiTeITAP3SJM2vULsRb7AUdlwi9EunKznk8hdDc3l1E130_provenance.
- assertion description "[Immunohistochemical detection of expression of the epidermal growth factor receptor (EGFR) has been utilized to identify eligible patients with solid malignant tumors, including colorectal adenocarcinoma, for monoclonal antibody therapy (eg, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_assertion description "[Immunohistochemical detection of expression of the epidermal growth factor receptor (EGFR) has been utilized to identify eligible patients with solid malignant tumors, including colorectal adenocarcinoma, for monoclonal antibody therapy (eg, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_provenance.
- NP370351.RAFCzhJ7m4EdYBfLnwP4SN39GuK5mhWeD4IG_Af-fH2jY130_assertion description "[Immunohistochemical detection of expression of the epidermal growth factor receptor (EGFR) has been utilized to identify eligible patients with solid malignant tumors, including colorectal adenocarcinoma, for monoclonal antibody therapy (eg, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370351.RAFCzhJ7m4EdYBfLnwP4SN39GuK5mhWeD4IG_Af-fH2jY130_provenance.